KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $429.9 million.

  • Novavax's Total Current Liabilities fell 6360.12% to $429.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.9 million, marking a year-over-year decrease of 6360.12%. This contributed to the annual value of $1.2 billion for FY2024, which is 2939.95% down from last year.
  • Per Novavax's latest filing, its Total Current Liabilities stood at $429.9 million for Q3 2025, which was down 6360.12% from $389.1 million recorded in Q2 2025.
  • Novavax's Total Current Liabilities' 5-year high stood at $2.5 billion during Q4 2022, with a 5-year trough of $389.1 million in Q2 2025.
  • For the 5-year period, Novavax's Total Current Liabilities averaged around $1.5 billion, with its median value being $1.6 billion (2023).
  • As far as peak fluctuations go, Novavax's Total Current Liabilities soared by 626684.75% in 2021, and later tumbled by 6639.02% in 2025.
  • Over the past 5 years, Novavax's Total Current Liabilities (Quarter) stood at $2.4 billion in 2021, then grew by 2.91% to $2.5 billion in 2022, then plummeted by 33.53% to $1.6 billion in 2023, then decreased by 29.4% to $1.2 billion in 2024, then tumbled by 62.76% to $429.9 million in 2025.
  • Its Total Current Liabilities stands at $429.9 million for Q3 2025, versus $389.1 million for Q2 2025 and $422.2 million for Q1 2025.